Diagnosis of Latent Tuberculosis

P Singh, A Govindaswamy - Diagnosis of Mycobacterium, 2023 - Springer
Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to
stimulation by Mycobacterium tuberculosis antigens without evidence of a clinically …

Predicting progression to active tuberculosis: a rate-limiting step on the path to elimination

A Lalvani, LC Berrocal-Almanza, A Halliday - PLoS Medicine, 2019 - journals.plos.org
Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination |
PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue …

Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study

F Kloprogge, I Abubakar, H Esmail, V Hack, H Kunst… - BMJ open, 2021 - bmjopen.bmj.com
Introduction An improved understanding of factors explaining tuberculosis (TB) treatment
response is urgently needed to help clinicians optimise and personalise treatment and …

Assessment of possible diagnostic and prognostic markers of tuberculosis

S Ubolyam - 2018 - unsworks.unsw.edu.au
Tuberculosis (TB) remains one of the leading causes of death. Delayed diagnosis and
treatment of TB as well as an emergence of drug-resistant TB are major problems in …

PO 8544 Use of Xpert MTB/RIF assay and FDA microscopy relative to monthly cultures in monitoring multidrug-resistant tuberculosis patients in bamako, mali

B Diarra, B Aissata, T Decroo, ML Keita, B Degoga… - 2019 - gh.bmj.com
Introduction Xpert MTB/RIF assay is used extensively for the detection of rifampicin-resistant
TB (RR-TB). RR-TB treatment monitoring is culture-based, although, in resource-limited …

C-reactive protein versus erythrocyte sedimentation rate in monitoring multidrug-resistant tuberculosis

MM Khalil, HAA Halim… - The Egyptian Journal of …, 2020 - journals.lww.com
Background Studies that validate new antituberculous regimens take much more time to
complete as mycobacteria tend to be cleared slowly with absence of valid biomarkers to …

Rapid monitoring of tuberculosis treatment response: A multi-centre study

WS Sabiiti, RB Bowness, SHG Gillespie… - 2016 - Eur Respiratory Soc
Tuberculosis (TB) is a global health emergency and the need to develop better tools for its
management have never been urgent. We report a performance evaluation of rapid …

B24 DIAGNOSIS AND TREATMENT IN THE SPECTRUM OF TUBERCULOSIS: Quantitative Xpert Mtb/rif To Assess Tuberculosis Treatment Response: Timing To …

A Jayakumar, CK Everett, D Benator… - American Journal of …, 2014 - search.proquest.com
METHODS: We obtained sputum samples from 115 adult patients at ten international sites
with smear-positive pulmonary tuberculosis enrolled in TB Trials Consortium 29X, a phase 2 …

Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China

P Lu, Q Liu, L Martinez, H Yang, W Lu… - European …, 2017 - Eur Respiratory Soc
Sputum culture plays an important role in monitoring treatment response in patients with
multidrug-resistant tuberculosis (MDR-TB), and sputum culture conversion is a clinical tool …

Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study

A Basit, N Ahmad, AH Khan, A Javaid… - PloS one, 2014 - journals.plos.org
Background Various studies have reported culture conversion at two months as a predictor
of successful treatment outcome in multidrug-resistant tuberculosis (MDR-TB). Objectives …